Reagents & Supplies in Biotechnology

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations I-1
• Disclaimers I-2
• Data Interpretation & Reporting Level I-2
• Quantitative Techniques & Analytics I-3
• Product Definitions and Scope of Study I-3
• Cell & Tissue Culture Reagents I-3
• DNA Synthesis & Sequencing Reagents I-4
• Electrophoresis Reagents I-4
• Flow Cytometry Reagents I-4
• Immunoassay Reagents I-4
• Liquid Chromatography Reagents I-5
• PCR Reagents I-5
• Protein Synthesis & Sequencing Reagents I-5

II. EXECUTIVE SUMMARY

1. Outlook II-1

• Analysis by Geographic Region II-1
• Analysis by Product Segment II-1
• Reagents Market Players Witnessing Paradigm Shift II-1

2. Market Dynamics II-2

• Highly Automated Instrumentation Restricts Use of Reagents II-2
• Software-Intensive Nature and High System Complexity Impedes Use of Automated Instruments II-2
• Demand for Diverse Products Spurs Growth II-2
• Increasing Use in Industrial Sector II-2
• Molecular Biology and Protein Synthesis Reagents - the Fastest Growing Segments II-3
• Obtaining Data from Enzyme Functions II-3
• New Economy Sees the Entry of Directed Evolution Enzymes II-3

3. Biotechnology - Industry Overview II-4

• Growing by Leaps and Bounds II-4
• Human Genome Mapping - A Colossal Milestone II-4
• High Growth Applications Spur Industry Growth II-5
• Biochips- Promising Future II-5
• Convergence of Distinct Technologies II-6
• Growing Collaboration between Biotech and Pharma Companies II-6

4. Product Overview II-7

• A. Classification II-7
• i. DNA Synthesis & Sequencing Reagents II-7
• DNA: The Basis for Modern Biotechnology II-7
• ii. PCR Reagents II-7
• iii. Protein Synthesis & Sequencing Reagents II-7
• iv. Electrophoresis Reagents II-8
• v. Bio/Chemiluminescence Reagents II-8
• vi. Immunoassay Reagents II-8
• Antibodies II-8
• Monoclonal and Polyclonal Antibodies II-8
• Types of Monoclonal Antibodies II-8
• a. Murine Monoclonal Antibodies II-8
• b. Human Antibodies II-9
• c. Chimeric Antibodies II-9
• d. Bispecific Antibodies II-9
• Hematology/Coagulation Reagents II-9
• vii. Chromatography Reagents II-9
• viii. Flow Cytometry Reagents II-9
• ix. Cell & Tissue Culture Reagents II-10

5. Product Innovations/Introductions II-11

• Ortho-Clinical Diagnostics Launches VITROS® Chemistry Products d%A1c Reagent II-11
• Beckman Coulter to Launch Access DHEA-S II-11
• Solulink Introduces ChromaLink II-11
• Cambrex Launches Versalinx Reagents II-11
• Kreatech Unveils a New Range of Isolation and Labeling Kits II-11
• Nanogen Launches Enterovirus Analyte Specific Reagent - MGB Alert™ II-11
• Olympus Unveils New Reagent Kit with Single Molecular Fluorescence Spectroscopy II-12
• SAFC Releases Proligo Reagents II-12
• LI-COR Biosciences Releases New IRDye® Western Kits for Odyssey® System II-12
• Altor Launches STAR™ Multimer Reagents II-12
• Guava Technologies Launches a New Range of Antibody Reagents II-12
• Solexa Launches Genome Analysis System II-12
• Daiichi Unveils New Reagent Kit II-12
• ReaMetrix Introduces Accuford II-13
• TriPath Imaging Unveils ProEx C II-13
• Roche and 454 Life Sciences Launches Genome Sequencer 20 System and Reagents II-13
• Chinese Academy of Military Medical Sciences IntroducesReagent to Test Drug Resistance of HBV II-13
• SIAL Unveils SYBR Green Extract-N-Amp Tissue PCR Kit II-13
• Aldrich Introduces LAB Reagents II-13
• Kreatech Rolls Out RNA ampULSe Amplification and Labeling Kits II-14
• BioM&eacure;rieux Launches NucliSens miniMAG and NucliSens Magnetic Extraction Reagents II-14
• Guava Technologies Launches a New Cell Cycle Assay II-14
• U.S. Genomics Introduces Direct miRNA Reagents for Trilogy Platform II-14
• Dharmacon Inc, Introduces siGENOME(TM) siRNA II-15
• Agencourt Bioscience Introduces RNA Isolation and Purification Kit II-15
• Caliper Life Sciences in Collaboration with Promega Offers Automation Protocols II-16
• French Researchers Develop Novel Sandwich
• Immunoassay for Small Molecule Study II-16
• Do-Coop Technologies Launches Water-based Nano-Reagent II-16
• Affymetrix Inc, Collaborates with Invitrogen to Launch Reagents for GeneChip II-16
• Roche Unveils Amplicor HPV in the US II-17
• Shimadzu Develops Reagent for Cell-Free Protein Synthesis II-17
• Roche Working on PCR-based Linear Array Test for HPV II-17
• Takara Bio Releases OmniMix HS II-17
• Cortex Biochem Unveils MagaZorb RNA Mini-Prep Kit II-17
• Invitrogen Launches cDNA Library Construction Kit II-18
• PharmaDesign Develops New Reagents II-18
• Tecan Systems Introduces DNA Extraction Kits II-18
• Proligo Introduces TrueSNP Primer Kit II-18
• Proligo Introduces TrueSNP Primer Kit II-18
• Invitrogen Launches OligofectAMINE Reagent II-18
• GeneMachines introduces New Line of OmniGrid Slides and Reagents II-18
• Third Wave Introduces Four New Invader Clinical Reagents II-19
• Mitsubishi Chemical, Wakenyaku and Toyobo Develop New Reagent II-19
• Amersham Biosciences Launches Reagent Kit II-19
• Beckman Coulter Unveils Ready-to-Use Histocompatibility Complex Tetramer Reagents II-20
• Prolinx Unveils Proteomics Products II-20
• Minerva Biolabs Launches Reagents and Diagnostic Kits II-20
• Molecular Devices Corp Launches Reagent Kits II-20
• Qiagen Releases ProofStart DNA Polymerase II-20
• Pyrosequencing Launches Reagent Kits and Sequence Analysis Software II-21
• Argonaut Technologies Launches Three Reagents II-21
• Trevigen Introduces Antibodies, Kits & Reagents II-21
• Link Technologies Launches Reagent Kit II-21
• Argonaut Technologies Launches Organic Synthesis and Purification Accelerating Reagents II-21
• Trevigen Inc., Introduces Antibodies, Kits And Reagents for Cell Death Study II-21
• Amersham Pharmacia Launches DYEnamic ET terminator DNA Sequencing Kit II-21
• Millipore Corp Launches Maestro Life Science Kits II-22

6. Recent Industry Activity II-23

• Takara Bio. Pharma Acquires Stakes in Takara
• Biotechnology II-23
• Millipore Takes Over Serologicals II-23
• Serologicals Takes Over LINCO II-23
• Genospectra Merges with Panomics II-23
• Roche Enters into Three-Year Contract with Premier II-23
• KREATECH and GenTel Enter into Distribution Agreement II-24
• Kreatech Enters into Supply Agreement with QIAGEN II-24
• Invitrogen to Provide Reagents for Genome equencing of Solexa II-24
• VWR International to Market Biocare Equipment and Reagents in IHC II-24
• Biocare Partners with Epitomics for Reagents II-24
• GE and CytoGenix Form an Alliance II-24
• Fisher Biosciences Joins Forces with Dyomics II-24
• PerkinElmer Partners with NCGC II-25
• SAFC-Biosciences Formed to Support Sigma-Aldrich II-25
• Takara Takes Over Clonetech II-25
• Techne' s Subsidiary Pockets BiosPacific and Fortron Bio Science II-25
• QIAGEN Obtains Nextal II-25
• Invitrogen Takes Over Caltag II-26
• Invitrogen Takes Over Biosource International II-26
• Serologicals Acquires Specialty Media from Sentigen II-26
• Invitrogen Acquires Zymed Laboratories II-26
• Biotage Acquires Argonaut Technologies II-26
• Invitrogen Acquires Dynal Biotech II-26
• Vita and Cortex Biochem Enter into Distribution Agreement II-26
• SIAL and OXB Sign an Agreement for CommercializingLentiVector Technology II-27
• Funakoshi and Affibody Sign a Distribution Agreement II-27
• KREATECH and GenTel Enter into Marketing Agreement II-27
• KREATECH and Ambion Enter into Supply Agreement II-27
• SIAL Enters into Distribution Agreement with MedAssets II-27
• IBT Signs Distribution Contracts for Enzymes II-27
• Epitome Signs a License Agreement with EMD Biosciences II-28
• Consorta Inks Multiple Agreements with Dade Behring II-28
• SCS and Chemicon Sign an Agreement for ES Cell Media II-28
• LSBC and BioCatalytics Enter into Collaborative Agreement for Producing Enzymes II-28
• Chemicon International Enters into an Agreement with QDC II-28
• Dharmacon Signs an Agreement with Genentech II-29
• Invitrogen Partners with PerkinElmer II-29
• Chemicon and Axordia Collaborate for New Antibody Markers II-29
• eGene Enters into Strategic Alliance with Transgenomic II-29
• Cancer Genetics Selects Genetics Specialities II-29
• Clinical Data Bags Distribution Rights for HematologyAnalyzers and Reagents II-30
• BD Biosciences to Expand Production in Puerto Rico II-30
• Olympus Enlarges R&D Unit in Ireland II-30
• Olympus Begins Production of Immunoassay Reagents II-30
• Koon-wah Leong, Shery Guo and Suyue Qian Produced Multilayer Test Strips II-30
• CMT Sells off Specialty Media Division II-30
• CSL Divests Cell Culture Reagent Business to Sigma-Aldrich II-30
• Hycor Biomedical Merges with Stratagene Corporation II-31
• GE Acquires Amersham plc II-31
• CalbaTech Snaps Up K-D Medical II-31
• Tepnel Life Sciences Acquires Diaclone Research SAS II-31
• BD Acquires Atto Bioscience II-31
• Invitrogen to Acquire Bio Asia II-32
• Idexx Announce Plans to Acquire Switzerland-based Bommeli II-32
• Chemicon Announce Plans to Acquire Product Lines from Primogenix II-32
• Bio-Rad Laboratories to Acquire MJ GeneWorks II-33
• D. Lansing Taylor Join Forces with PLSG to Create Cellumen II-33
• eGene Inc. and Prisma Biotech form Distribution Alliance II-33
• eGene Alliances with HVD Life Science and HVD Biotech Vertriebs-GmbH II-33
• Cell Signaling Technology, Inc. and Zeptosens AG Sign Licensing Agreement for CST reagents II-34
• Pierce and Tecan Enter into Drug Discovery Covenant II-34
• Syntonix and Dyax Enter into Antibody Discovery Pact II-34
• NeoPharm Signs an Agreement with Nippon Genetics II-35
• Amersham Signs Distribution Agreement with Guava Technologies II-35
• CST and LI-COR Sign an Agreement II-35
• Cell Signaling Technology, Inc. Signs Agreement with ProQinase GmbH II-35
• Sigma-Aldrich Signs a Distribution Agreement with Avecia II-36
• LSBC and Sigma-Aldrich Enter into Recombinant Aprotinin Agreement II-36
• Atugen Signs a Contract Research Agreement with Eisai II-36
• CII Enters into Sub-License Agreement with Promega II-36
• Dharmacon Signs Agreement with Wyeth Pharmaceuticals II-37
• SurModics inks Distribution Agreement with SeraCare Life Sciences II-37
• Hydra Biosciences Signs Agreement with Evotec OAI AG II-37
• Chemicon International Strikes a Deal with Thromb-X N.V. II-37
• Ambion Inks Agreement with Applied Biosystems II-38
• Cosmo Bio Establishes New US Subsidiary II-38
• Agilent Technologies Inc, Establishes Integrated Biology Solutions Unit II-38
• BD Plans to Divest Clontech Business II-38
• CeMines Completes Expansion Program II-38
• Definiens AG Enters into an Agreement with SERVA Electrophoresis II-39
• DNA Research Innovations Scrip Agreement with Tecan UK II-39
• Perbio Acquires FBS Supplier in Australia II-39
• Molecular Devices Consummates Acquisition of Argonex II-39
• Perkin-Elmer Acquires Packard BioScience II-40
• Invitrogen Acquires Dexter Corp and Life Science Technologies II-40
• Luminex and Upstate Biotechnology Enter into Partnership II-40
• Maxim Biotech Enters into Promotional Agreement with Agilent Technologies II-40
• Luminex Forges Pact with Lifecodes II-40
• BioInvent International Signs Agreement with Novo Nordisk II-41
• Varian Acquires Liquid Chromatography Products From R&S Technology' s Line II-41
• Luminex Grants Nonexclusive Rights to R&D Systems II-41
• Visible Genetics Receives FDA Approval for TRUGENE HIV-1 Genotyping Kit II-41
• Commonwealth Biotechnologies Receives Patent for AccuTrac II-41

7. Focus on Select Players Worldwide II-42

• Abbott Diagnostics (US) II-42
• Applied Biosystems (US) II-42
• Beckman Coulter, Inc. (US) II-42
• Becton Dickinson and Company (US) II-42
• Biomerieux (France) II-43
• Chemicon International, Inc. (US) II-43
• Cortex Biochem Inc. (US) II-43
• Dade Behring (US) II-43
• EMD Biosciences (US) II-44
• GE Healthcare (US) II-44
• Invitrogen Corporation (US) II-44
• Ortho-Clinical Diagnostics (US) II-45
• PerkinElmer, Inc. (US) II-45
• Promega Corporation (US) II-45
• Roche Diagnostics (Switzerland) II-45
• Sigma - Aldrich (US) II-46

8. Global Market Perspective II-47

• Table 1: World Recent Past, Current & Future Market Analysis for Reagents in Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-47
• Table 2: World 10-Year Perspective for Reagents in Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-47
• Table 3: World Recent Past, Current & Future Market Analysis for Cell / Tissue Culture Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-48
• Table 4: World 10-Year Perspective for Cell / Tissue Culture Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-48
• Table 5: World Recent Past, Current & Future Market Analysis for DNA Sequencing / Synthesis Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-49
• Table 6: World 10-Year Perspective for DNA Sequencing/Synthesis Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-49
• Table 7: World Recent Past, Current & Future Market Analysis for Electrophoresis Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-50
• Table 8: World 10-Year Perspective for Electrophoresis Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-50
• Table 9: World Recent Past, Current & Future Market Analysis for Flow Cytometry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-51
• Table 10: World 10-Year Perspective for Flow Cytometry Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-51
• Table 11: World Recent Past, Current & Future Market Analysis for Immunoassay Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-52
• Table 12: World 10-Year Perspective for Immunoassay Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-52
• Table 13: World Recent Past, Current & Future Market Analysis for Liquid Chromatography Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-53
• Table 14: World 10-Year Perspective for Liquid Chromatography Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-53
• Table 15: World Recent Past, Current & Future Market Analysis for Polymerase Chain Reaction Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-54
• Table 16: World 10-Year Perspective for Polymerase Chain Reaction Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-54
• Table 17: World Recent Past, Current & Future Market Analysis for Protein Synthesis Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-55
• Table 18: World 10-Year Perspective for Protein Synthesis Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-55

III. MARKET

1. United States III-1

• A. Market Analysis III-1
• Biotech Industry in the US III-1
• Escalating Demand for Biomedical Research Reagents and Kits III-1
• Application-Oriented Products Herald a Technological Upheaval III-2
• Competition - Highly Prevalent III-2
• Review of US Cell/Tissue Culture Supplies Market III-2
• Industrial Segment -Largest End-User III-2
• Rise in Cell Culture Equipment Demand Leads to Innovation III-3
• Factors Influencing the Market for Media III-3
• Fetal Bovine Serum - Use on a Decline III-3
• Table 19: Leading Producers of Fetal Bovine Serum in the US (2004): Percentage Breakdown of Value Sales for Life Technologies, Hyclone, and Others (includes corresponding Graph/Chart) III-3Suppliers Searching for New Areas III-4Serum Free Products Market: Rapidly Growing III-4 Immunoassay Reagents III-4
• Table 20: Leading Players in the US Immunoassay Reagents Market (2004): Percentage Breakdown of Value Sales for Abbott Diagnostics, Dade Behring, Roche Diagnostics, Beckman Coulter, and Others (includes corresponding Graph/Chart) III-4
• Issues Affecting the US Immunodiagnostics Market III-5
• Technological Innovations Play a Vital Role III-5
• Molecular Biological Reagents III-5
• Rapidly Growing Market III-5
• Table 21: Molecular Biology Reagents Market in the US (2004): Percentage Breakdown of Value Sales by End use for Academic User, Biotech industry, Pharmaceuticals, and Government (includes corresponding Graph/Chart) III-5
• DNA Sequencing: Gaining Prominence III-5
• Key Players III-6
• Abbott Diagnostics III-6
• Applied Biosystems III-6
• Beckman Coulter, Inc. III-6
• Becton Dickinson and Company III-7
• Chemicon International, Inc III-7
• Cortex Biochem Inc. III-7
• Dade Behring III-7
• EMD Biosciences III-8
• GE Healthcare III-8
• Invitrogen Corporation III-8
• Ortho-Clinical Diagnostics III-8
• PerkinElmer, Inc III-8
• Promega Corporation III-9
• Sigma - Aldrich III-9
• Product Launches III-9
• Strategic Developments III-16
• B. Market Analytics III-27
• Table 22: US Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-27
• Table 23: US 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-28

2. Canada III-29

• A. Market Analysis III-29
• Biotech Sector in Canada III-29
• Outlook III-29
• Biotech Reagents Market Overview III-29
• Strategic Development III-29
• B. Market Analytics III-30
• Table 24: Canadian Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-30
• Table 25: Canadian 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid ChromatographyReagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-31

3. Japan III-32

• A. Market Analysis III-32
• Biotech Scenario III-32
• Outlook III-33
• Product Launches III-33
• Strategic Development III-34
• B. Market Analytics III-36
• Table 26: Japanese Recent Past, Current & Future
• Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently
• Analyzed with Annual Sales Figures in US$ Million
• for Years 2000 through 2010 (includes corresponding Graph/Chart) III-36
• Table 27: Japanese 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein
• Synthesis Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-37

4. Europe III-38

• A. Market Analysis III-38
• Biotechnology in Europe on an Expansion Spree III-38
• Key Players III-38
• Biomerieux (France) III-38
• Roche Diagnostics (Switzerland) III-38
• Product Launches III-39
• Strategic Developments III-39
• B. Market Analytics III-41
• Table 28: European Recent Past, Current & Future Analysis for Reagents in Biotechnology by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-41
• Table 29: European 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-41
• Table 30: European Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-42
• Table 31: European 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-43

4a. France III-44

• Market Analysis III-44
• Table 32: French Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-44
• Table 33: French 10-Year Perspective for Reagents inBiotechnology by Product Segment - PercentageBreakdown of Dollar Sales for Cell/Tissue CultureReagents, DNA Sequencing/ Synthesis Reagents,Electrophoresis Reagents, Flow Cytometry Reagents,Immunoassay Reagents, Liquid ChromatographyReagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years2000, 2006 & 2010 (includes corresponding Graph/Chart) III-45

4b. Germany III-46

• A. Market Analysis III-46
• German Biotech Industry Review III-46
• Outlook III-46
• Strategic Development III-47
• Key Player Review III-47
• GE Healthcare/Amersham Plc III-47
• B. Market Analytics III-48
• Table 34: German Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-48
• Table 35: German 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-49

4c. Italy III-50

• Market Analysis III-50
• Table 36: Italian Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-50
• Table 37: Italian 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-51

4d. The United Kingdom III-52

• A. Market Analysis III-52
• Research Entities III-52
• Commercial Activities III-52
• Strategic Developments III-52
• B. Market Analytics III-53
• Table 38: UK Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through
• 2010 (includes corresponding Graph/Chart) III-53
• Table 39: UK 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein
• Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-54

4e. Rest of Europe III-55

• A. Market Analysis III-55
• Medical Device Market in Spain III-55
• Russian Clinical Diagnostic Equipment and
• Supplies Market III-55
• Major Reagent Producers III-55
• Product Launches III-56
• Strategic Developments III-56
• B. Market Analytics III-57
• Table 40: Rest of Europe Market for Reagents in Biotechnology - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-57
• Table 41: Rest of Europe 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein
• ynthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-58

5. Asia-Pacific III-59

• A. Market Analysis III-59
• Biotechnology- A Burgeoning Market III-59
• Impact of IPR on Biotechnology Market III-59
• Asia-Pacific - A Lucrative R&D Base III-59
• Focus on Key Biotechnology Markets III-60
• India III-60
• China III-60
• Korea III-61
• Clinical Lab Products Market in Korea III-61
• Product Launches III-61
• Strategic Developments III-61
• B. Market Analytics III-63
• Table 42: Asia-Pacific Market for Reagents in Biotechnology Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-63
• Table 43: Asia-Pacific 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-64

6. Latin America III-65

• Market Analysis III-65
• Table 44: Latin American Market for Reagents in Biotechnology - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-65
• Table 45: Latin American 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-66

IV. COMPETITION

• 1. 454 Life Sciences (USA) IV-1
• 2. Abbott Diagnostics Division of Abbott Laboratories (USA) IV-2
• 3. Abcell Oy (Finland) IV-13
• 4. Abcys SA (France) IV-14
• 5. Accurate Chemical & Scientific Corporation (USA) IV-16
• 6. Adaltis, Inc. (Canada) IV-17
• Adaltis Deutschland GmbH (Germany) IV-19
• Adaltis Italia SpA (Italy) IV-19
• 7. Advanced Biotechnologies, Inc. (USA) IV-20
• 8. Advanced ChemTech, Inc. (USA) IV-23
• 9. AES Laboratoire (France) IV-24
• 10. Affibody AB (Sweden) IV-25
• Table 46: Annual Sales Analysis: 2004-2005 (In SEK million) IV-25
• 11. Affinity BioReagents, Inc. (USA) IV-26
• 12. Agdia, Inc. (USA) IV-28
• 13. Agilent Technologies, Inc. (USA) IV-32
• Table 47: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-34
• Table 48: Annual Sales Analysis: 2004-2005 (In US$ million) IV-34
• Table 49: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-34
• Table 50: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-35
• Table 51: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-35
• 14. AH Diagnostics AS (Denmark) IV-46
• AH Diagnostics AB (Sweden) IV-46
• 15. Alba Bioscience (UK) IV-47
• 16. AlerCHEK, Inc. (USA) IV-47
• 17. Alltech Associates, Inc. (USA) IV-48
• 18. Alpha Diagnostic International, Inc. (USA) IV-56
• 19. Alpha Innotech Corporation (USA) IV-60
• Table 52: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-60
• Table 53: Annual Sales Analysis: 2004-2005 (In US$ million) IV-61
• Table 54: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-61
• Table 55: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-61
• 20. Altor BioScience Corporation (USA) IV-63
• 21. American Bioanalytical, Inc. (USA) IV-64
• 22. American Qualex (USA) IV-66
• 23. American Type Culture Collection (USA) IV-67
• 24. Amgen, Inc. (USA) IV-70
• Table 56: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-71
• Table 57: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-71
• Table 58: Annual Sales Analysis: 2004-2005 (In US$ million) IV-71
• Table 59: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-71
• Table 60: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-72
• 25. Amphotech Limited (USA) IV-75
• 26. Amresco, Inc. (USA) IV-77
• 27. Anachemia Chemicals, Inc. (USA) IV-78
• 28. Antigenix America, Inc. (USA) IV-80
• 29. Applichem GmbH (Germany) IV-84
• 30. Applied Biosystems (USA) IV-85
• Table 61: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
• Table 62: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
• Table 63: Nine Months Sales Analysis by Product: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
• Table 64: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
• Table 65: Annual Sales Analysis: 2004-2005 (In US$ billion) IV-87Table 66: Annual Sales Analysis by Quarter: 2004-2005 (In US$ billion) IV-87
• Table 67: Annual Sales Analysis by Segment: 2004-2005 (In US$ billion) IV-87
• Table 68: Annual Sales Analysis by Product: 2004-2005 (In US$ billion) IV-87
• Table 69: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion) IV-88
• Ambion, Inc. (USA) IV-92
• 31. Argonaut Technologies, Inc (USA) IV-93
• 32. Australian Laboratory Services Pty., Ltd. (Australia) IV-94
• 33. Avanti Polar Lipids, Inc. (USA) IV-96
• 34. Axis-Shield PLC (UK) IV-98
• Table 70: Annual Sales Analysis: 2004-2005 (In £ million) IV-98
• Table 71: Annual Sales Analysis by Segment: 2004-2005 (In £ million) IV-99
• 35. Axordia Limited (UK) IV-100
• 36. Bachem AG (Switzerland) IV-102
• Table 72: Half Yearly Sales Analysis: 2005-2006 (H1) (In CHF million) IV-102Table 73: Annual Sales Analysis: 2004-2005 (In CHF million) IV-103
• Table 74: Annual Sales Analysis by Segment: 2004-2005 (In CHF million) IV-103
• Table 75: Annual Sales Analysis by Geographic Region: 2004-2005 (In CHF million) IV-103
• Bachem (UK) Ltd. (UK) IV-107
• Bachem Biochemica GmbH (Germany) IV-107
• 37. Beckman Coulter, Inc. (USA) IV-108
• Table 76: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-112
• Table 77: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-112
• Table 78: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-112
• Table 79: Annual Sales Analysis: 2004-2005 (In US$ million) IV-112
• Table 80: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-112
• Table 81: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-113
• Beckman Coulter GmbH (USA) IV-116
• Diagnostic Systems Laboratories, Inc. (USA) IV-118
• Lumigen, Inc. (USA) IV-119
• 38. Becton, Dickinson & Company (USA) IV-120
• Table 82: Nine Months Sales Analysis: 2005-2006
• (Nine Months Ended, June) (In US$ million) IV-122
• Table 83: Nine Months Sales Analysis by Quarter:
• 2005-2006 (Nine Months Ended, June) (In US$ million) IV-122
• Table 84: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-122
• Table 85: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-122
• Table 86: Annual Sales Analysis: 2004-2005 (In US$ million) IV-122
• Table 87: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-123
• Table 88: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-123
• Table 89: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-123
• BD Biosciences (USA) IV-128
• BD Diagnostic Systems (USA) IV-144
• BD Immunocytometry Systems (USA) IV-146
• 39. Biocare Medical LLC (USA) IV-147
• 40. Biocell Laboratories, Inc (USA) IV-148
• 41. Biochemical Diagnostics, Inc. (USA) IV-150
• 42. Biocientifica SA (Argentina) IV-154
• 43. Bioclone Australia Pty., Ltd (Australia) IV-155
• 44. BioFX Laboratories, Inc. (USA) IV-156
• 45. BioGenex Laboratories, Inc. (USA) IV-158
• 46. Biologos, Inc. (USA) IV-161
• 47. Biomar Diagnostic Systems GmbH (Germany) IV-162
• 48. Biomeda Corporation (USA) IV-163
• 49. Biomerieux SA (France) IV-169
• Table 90: Half Yearly Sales Analysis: 2005-2006 (H1) (In € million) IV-170
• Table 91: Half Yearly Sales Analysis by Segment: 005-2006 (H1) (In € million) IV-170
• Table 92: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In € million) IV-171
• Table 93: Annual Sales Analysis: 2004-2005 (In € million) IV-171
• Table 94: Annual Sales Analysis by Segment: 2004-2005 (In € million) IV-171
• Table 95: Annual Sales Analysis by Geographic Region: 2004-2005 (In € million) IV-171
• Biomerieux, Inc. (USA) IV-176
• Biomerieux Espana SA (Spain) IV-179
• 50. Biomidi (France) IV-180
• 51. Biomol GmbH (Germany) IV-181
• Biomol Research Laboratories, Inc. (USA) IV-186
• 52. Bion Enterprises Limited (USA) IV-189
• 53. BioNova Cientifica SL (Spain) IV-189
• 54. Bio-Rad Laboratories, Inc. (USA) IV-190
• Table 96: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-191
• Table 97: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-192
• Table 98: Annual Sales Analysis: 2004-2005 (In US$ million) IV-192
• Table 99: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-192
• Table 100: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-192
• Table 101: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-192
• Bio-Rad Laboratories - Life Science Group Divison (USA) IV-202
• Bio-Rad Laboratories (UK) Ltd. (UK) IV-203
• 55. Bioreba AG (Switzerland) IV-204
• 56. Biosearch Technologies, Inc. (USA) IV-205
• 57. Biospa Division (Italy) IV-210
• 58. BiosPacific, Inc. (USA) IV-210
• 59. Biosynth AG (Switzerland) IV-211
• 60. Biotech India (India) IV-212
• 61. Biotech-IgG AS (Denmark) IV-213
• 62. Biotecx Laboratories, Inc. (USA) IV-214
• 63. Biotest AG (Germany) IV-215
• Biotest Diagnostics Corporation (USA) IV-216
• Biotest (UK) Limited (UK) IV-218
• 64. Biotrend Chemikalien GmbH (Germany) IV-220
• 65. Biovalley SA (France) IV-223
• 66. BioVectra DCL (Canada) IV-225
• 67. Biozol Diagnostica Vertrieb GmbH (Germany) IV-226
• 68. Biozyme Laboratories Limited (UK) IV-228
• 69. Blue Heron Biotechnology, Inc. (USA) IV-229
• 70. Brand-Nu Laboratories (USA) IV-230
• 71. British Biocell International Limited (UK) IV-231
• Table 102: Annual Sales Analysis: 2005-2006 (In £ billion) IV-231
• Table 103: Annual Sales Analysis by Segment: 2005-2006: (In £ billion) IV-231
• 72. CalbaTech, Inc. (USA) IV-233
• Table 104: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-234
• Table 105: Annual Sales Analysis: 2004-2005 (In US$ million) IV-234
• 73. Cambio Limited (UK) IV-235
• 74. Cambrex Corporation (USA) IV-239
• Table 106: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-241
• Table 107: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-241
• Table 108: Annual Sales Analysis: 2004-2005 (In US$ million) IV-241
• Table 109: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-241
• Cambrex Bio Science Rockland, Inc. (USA) IV-246
• 75. Cambridge Life Sciences PLC (UK) IV-247
• 76. Carl Roth GmbH & Co. (Germany) IV-248
• 77. Carlo Erba Reagenti Srl (Italy) IV-249
• 78. Cayman Chemical Co. (USA) IV-250
• 79. Cedarlane Laboratories Limited (Canada) IV-253
• 80. Celbio Srl (Italy) IV-253
• 81. Cell Sciences, Inc. (USA) IV-254
• 82. Celltech Group PLC (UK) IV-255
• 83. Chemicon International, Inc. (USA) IV-256
• Chemicon Australia Pty., Ltd. (Australia) IV-260
• 84. Chromogenix Instrumentation Laboratory SpA (Italy) IV-262
• 85. Ciphergen Biosystems, Inc. (USA) IV-263
• Table 110: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-264
• Table 111: Annual Sales Analysis: 2004-2005 (In US$ million) IV-264
• 86. Consorta, Inc. (USA) IV-267
• 87. Continental Lab Products, Inc. (USA) IV-268
• 88. Cortex Biochem, Inc. (USA) IV-270
• 89. D&F Control Systems, Inc. (USA) IV-274
• 90. Dade Behring, Inc. (USA) IV-275
• Table 112: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-276
• Table 113: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-277
• Table 114: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-277
• Table 115: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-277
• Table 116: Annual Sales Analysis: 2004-2005 (In US$ million) IV-277
• Table 117: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-277
• Table 118: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-278
• Table 119: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-278
• 91. Daiichi Pure Chemicals Co., Ltd. (Japan) IV-299
• 92. Dakocytomation Denmark A/S (Denmark) IV-300
• Dakocytomation (USA) IV-302
• Dakocytomation Ltd. (UK) IV-303
• 93. DCS Innovative Diagnostik Systeme (Germany) IV-306
• 94. Diagnostic Biosystems (USA) IV-307
• 95. Diagnostic Technology (Australia) IV-309
• 96. Diagnostix Limited (Canada) IV-310
• 97. DiaSorin SpA (Italy) IV-313
• Diasorin, Inc. (USA) IV-314
• 98. Diatech Srl (Italy) IV-316
• 99. Dionex Corporation (USA) IV-317
• Table 120: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, March) (In US$ million) IV-318
• Table 121: Annual Sales Analysis: 2004-2005 (In US$ million) IV-318
• 100. Drew Scientific Group PLC (UK) IV-328
• 101. DRG Instruments GmbH (Germany) IV-329
• 102. Dyax Corporation (USA) IV-330
• Table 122: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-331
• Table 123: Annual Sales Analysis: 2004-2005 (In US$ million) IV-331
• Table 124: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-331
• 103. EastCoast Bio, Inc. (USA) IV-333
• 104. Epicentre Biotechnologies (USA) IV-333
• 105. Epitome Biosystems (USA) IV-334
• 106. Epitomics, Inc. (USA) IV-335
• 107. Eppendorf (USA) IV-337
• 108. ESA Biosciences, Inc. (USA) IV-338
• 109. Exalpha Biologicals, Inc. (USA) IV-340
• 110. Exiqon A/S (Denmark) IV-341
• 111. E-Y Laboratories, Inc. (USA) IV-342
• 112. Fermentas, Inc. (USA) IV-343
• 113. Finnzymes Oy (Finland) IV-344
• 114. Fisher Biosciences (USA) IV-345
• ABgene (UK) IV-346
• 115. Fitzgerald Industries International, Inc. (USA) IV-348
• 116. FMC Corporation (USA) IV-349
• Table 125: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-351
• Table 126: Annual Sales Analysis: 2004-2005 (In US$ million) IV-351
• Table 127: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-352
• Table 128: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-352
• Table 129: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-352
• 117. Gallus Immunotech, Inc. (Canada) IV-356
• 118. GE Healthcare (USA) IV-358
• 119. Genaxis Biotechnology (France) IV-377
• 120. Genemed Biotechnologies, Inc. (USA) IV-378
• 121. General Biologicals, Inc. (Taiwan) IV-379
• 122. Genhunter Corporation (USA) IV-381
• 123. Geno Technology, Inc. (USA) IV-385
• 124. Genzyme Diagnostics (USA) IV-398
• 125. Glen Research Corporation (USA) IV-399
• 126. Goodwin Biotechnology, Inc. (USA) IV-403
• 127. GroPep Limited (Australia) IV-405
• Table 130: Annual Sales Analysis: 2005-2006 (In A$ million) IV-407
• Table 131: Annual Sales Analysis by Business Segment: 2005-2006 (In A$ million) IV-407
• 128. Guava Technologies, Inc. (USA) IV-409
• 129. Guildhay Ltd. (UK) IV-412
• 130. Helena Laboratories, Inc. (USA) IV-413
• 131. Histo-Line Laboratories (Italy) IV-415
• 132. Honeywell Burdick & Jackson (USA) IV-416
• 133. Hycult Biotechnology BV (The Netherlands) IV-418
• 134. Hytest Ltd. (Finland) IV-419
• 135. Ibex Technologies, Inc., (IBT) (Canada) IV-421
• 136. IBL Gesellschaft Fur Immunchemie Und Immunbiologie MBH (Germany) IV-422
• 137. IBT - Immunological & Biochemical Test systems GmbH (Germany) IV-423
• 138. Imgenex Corporation (USA) IV-424
• 139. Illumina, Inc. (USA) IV-426
• Table 132: Annual Sales Analysis: 2005-2006 (In US$ million) IV-426
• Table 133: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million) IV-427
• Table 134: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-427
• 140. IMMCO Diagnostics (USA) IV-432
• 141. Immucor, Inc. (USA) IV-433
• Table 135: First Quarter Sales Analysis: 2006-2007 (In US$ million) IV-433
• Table 136: First Quarter Sales Analysis by Geographic: 2006-2007 (In US$ million) IV-434
• Table 137: Annual Sales Analysis: 2004-2006 (In US$ million) IV-434
• Table 138: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million) IV-434
• Table 139: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-435
• Table 140: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-435
• Table 141: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-435
• 142. Immunicon Corporation (USA) IV-438
• Table 142: Annual Sales Analysis: 2004-2005 (In US$ million) IV-438
• Table 143: Annual Sales Analysis by Geographic
• Region: 2004-2005 (In US$ million) IV-439
• 143. Immunochemistry Technologies LLC (USA) IV-441
• 144. Immunolab GmbH (Germany) IV-441
• 145. Immunos (USA) IV-442
• 146. Inalco Group (Italy) IV-445
• 147. Inamco International Corporation (USA) IV-447
• 148. Inbios Srl (Italy) IV-448
• 149. Incell Corporation LLC (USA) IV-449
• 150. Incyte Genomics (USA) IV-451
• 151. Inverness Medical Innovations, Inc. (USA) IV-452
• Table 144: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-452
• Table 145: Annual Sales Analysis: 2004-2005 (In US$ million) IV-453
• Table 146: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-453
• Table 147: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-453
• Table 148: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-453
• 152. Invitrogen Corporation (USA) IV-455
• Table 149: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-456
• Table 150: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-456
• Table 151: Annual Sales Analysis: 2004-2005 (In US$ million) IV-456
• Table 152: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-456
• Table 153: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-457
• Caltag Laboratories, Inc. (USA) IV-463
• 153. Jackson Immunoresearch Laboratories, Inc. (USA) IV-465
• 154. Johnson & Johnson (USA) IV-466
• Table 154: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-468
• Table 155: Nine Months Sales Analysis by Segment:
• 2005-2006 (Nine Months Ended, September) (In US$ million) IV-468
• Table 156: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-468
• Table 157: Annual Sales Analysis: 2004-2005 (In US$ million) IV-468
• Table 158: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-469
• Table 159: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-469
• Ortho-Clinical Diagnostics (USA) IV-477
• 155. Kamiya Biomedical Company (USA) IV-480
• 156. Kamtek, Inc. (USA) IV-482
• 157. Kem-EN-Tec Diagnostics A/S (Denmark) IV-483
• 158. Kent Labs, Inc. (USA) IV-484
• 159. Kirkegaard & Perry Laboratories, Inc. (USA) IV-485
• 160. KMI Diagnostics, Inc. (USA) IV-486
• 161. Koma Biotech, Inc. (Korea) IV-486
• 162. Kreatech Diagnostic/Kreatech Biotechnology BV (The Netherlands) IV-487
• 163. Laboratories Eurobio SA (France) IV-489
• 164. Labscan Limited (Ireland) IV-489
• 165. Lampire Biological Laboratories (USA) IV-490
• 166. Lennox Laboratory Supplies Ltd. (Ireland) IV-491
• 167. LI-COR Biosciences (USA) IV-492
• 168. Loxo GmbH - Immunbiologie-Biochemie Products
• Und Systems (Germany) IV-494
• 169. MacConnell Research Corporation (USA) IV-494
• 170. Maine Biotechnology Services, Inc. (USA) IV-495
• 171. Mallinckrodt Baker, Inc. (USA) IV-496
• 172. Marker Gene Technologies, Inc. (USA) IV-498
• 173. Mascia Brunelli SpA (Italy) IV-499
• 174. Matritech, Inc. (USA) IV-500
• Table 160: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-501
• Table 161: Annual Sales Analysis: 2004-2005 (In US$ million) IV-501
• 175. Matrix Technologies Corporation (USA) IV-502
• 176. MD Biosciences, Inc. (USA) IV-504
• 177. Medarex, Inc. (USA) IV-505
• Table 162: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-506
• Table 163: Annual Sales Analysis: 2004-2005 (In US$ million) IV-506
• Table 164: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-506
• 178. Mediatech, Inc. (USA) IV-509
• 179. Medical Chemical Corporation (USA) IV-510
• 180. Medicorp, Inc. (Canada) IV-511
• 181. Medi-Cult A/S (Denmark) IV-512
• 182. Medix Biochemica OY AB (Finland) IV-514
• 183. Merck KgaA (Germany) IV-515
• Table 165: Annual Sales Analysis: 2004-2005 (In € million) IV-517
• Table 166: Annual Sales Analysis Segment: 2004-2005 (In € million) IV-517
• EMD Biosciences, Inc. (USA) IV-521
• Merck Ltd. (Taiwan) IV-526
• 184. Meridian Bioscience, Inc. (USA) IV-527
• Table 167: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-529
• Table 168: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-529
• Table 169: Annual Sales Analysis: 2004-2005 (In US$ million) IV-529
• Table 170: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-529
• Table 171: Annual Sales Analysis by Business Segment: 2004-2005 (In US $ million) IV-530
• Biodesign International (USA) IV-532
• OEM Concepts, Inc. (USA) IV-534
• 185. Microbix Biosystems, Inc. (Canada) IV-535
• Table 172: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-535
• 186. Microzone Limited (UK) IV-537
• 187. Midland Bioproducts Corporation (MBC) (USA) IV-538
• 188. Mikro+Polo (Slovenia) IV-539
• 189. Millipore Corporation (USA) IV-540
• Table 173: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-541
• Table 174: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In US$ million) IV-541
• Table 175: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-541
• Table 176: Annual Sales Analysis: 2004-2005 (In US$ million) IV-541
• Table 177: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-541
• Table 178: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-542
• Table 179: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-542
• Millipore GesmbH (Austria) IV-547
• Millipore SA NV (Belgium) IV-548
• 190. Miltenyi Biotec GmbH (Germany) IV-549
• 191. Mobitec GmbH (Germany) IV-550
• 192. Molecular Biosciences, Inc. (USA) IV-551
• 193. Molecular Devices Corporation (USA) IV-552
• Table 180: First Quarter Sales Analysis:
• 2005-2006 (In US$ million) IV-553
• Table 181: Annual Sales Analysis: 2004-2005 (In US$ million) IV-553
• Table 182: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-553
• Table 183: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-553
• Table 184: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-554
• Molecular Devices GmbH (Germany) IV-557
• 194. Molecular Research Center, Inc. (USA) IV-558
• 195. Monobind, Inc. (USA) IV-560
• 196. Moss, Inc. (USA) IV-560
• 197. MP Biomedicals (USA) IV-561
• 198. Mubio Products BV (The Netherlands) IV-562
• 199. Nanogen, Inc. (USA) IV-563
• Table 185: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-564
• Table 186: Annual Sales Analysis: 2004-2005 (In US$ million) IV-564
• 200. Nanoprobes, Inc. (USA) IV-569
• 201. National Diagnostics, Inc. (USA) IV-570
• 202. Neogen Corporation (USA) IV-571
• Table 187: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, February) (In US$ million) IV-572
• Table 188: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, February) (In US$ million) IV-572
• Table 189: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, February) (In US$ million) IV-572
• Table 190: Annual Sales Analysis: 2004-2005 (In US$ million) IV-573
• Table 191: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-573
• Table 192: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-573
• Table 193: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-573
• 203. New England Biolabs, Inc. (USA) IV-576
• New England Biolabs (UK) Ltd. (UK) IV-578
• 204. Nordic Immunological Laboratories (The Netherlands) IV-579
• 205. Novachem Pty., Ltd. (Australia) IV-579
• 206. Novocastra Laboratories Ltd. (UK) IV-580
• 207. Novozymes, Inc. (USA) IV-580
• 208. Olympus Life And Material Science Europa GmbH (Germany) IV-581
• 209. Onbio, Inc. (Canada) IV-582
• 210. One Lambda, Inc. (USA) IV-582
• 211. Orasure Technologies, Inc. (USA) IV-583
• Table 194: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-584
• Table 195: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-584
• Table 196: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-584
• Table 197: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-584
• Table 198: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-585
• Table 199: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-585
• 212. Orpegen Pharma GmbH (Germany) IV-589
• 213. Oxford Biomedical Research, Inc. (USA) IV-590
• 214. OXIS International, Inc. (USA) IV-591
• Table 200: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-591
• Table 201: Annual Sales Analysis: 2004-2005 (In US$ million) IV-592
• 215. P.J. Cobert Associates, Inc. (USA) IV-592
• 216. Panbio Ltd. (Australia) IV-593
• Table 202: Annual Sales Analysis: 2005-2006 (In A$ million) IV-593
• Table 203: Annul Sales Analysis by Geographic Region: 2005-2006 (In A$ million) IV-593
• Panbio, Inc. (USA) IV-594
• 217. Panomics, Inc. (USA) IV-595
• 218. PBL Biomedical Laboratories (USA) IV-596
• 219. Peprotech, Inc. (USA) IV-596
• 220. PerkinElmer, Inc. (USA) IV-597
• Table 204: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-598
• Table 205: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-598
• Table 206: Annual Sales Analysis: 2004-2005 (In US$ million) IV-599
• Table 207: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million): IV-599
• Table 208: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-599
• Table 209: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-599
• Perkinelmer Life And Analytical Sciences, Inc. (USA) IV-609
• 221. Pickering Laboratories, Inc. (USA) IV-610
• 222. Pierce Biotechnology, Inc. (USA) IV-610
• 223. Pointe Scientific, Inc. (USA) IV-611
• 224. Prime Synthesis, Inc. (USA) IV-612
• 225. Primm Labs, Inc. (USA) IV-614
• 226. Progen Biotechnik GmbH (Germany) IV-615
• 227. Promega Corporation (USA) IV-617
• Promega Biosciences, Inc. (USA) IV-618
• Promega Corporation (Australia) IV-619
• Promega UK Limited (UK) IV-619
• 228. Promocell GmbH (Germany) IV-622
• 229. Protein Technologies, Inc. (USA) IV-624
• 230. Protoprobe, Inc. (USA) IV-624
• 231. Protos Immunoresearch (USA) IV-625
• 232. Prozyme, Inc. (USA) IV-626
• 233. Qbiogene, Inc. (USA) IV-627
• 234. Qed Bioscience, Inc. (USA) IV-628
• 235. Qiagen NV (The Netherlands) IV-630
• Table 210: Annual Sales Analysis: 2004-2005 (In US$ million) IV-630
• Table 211: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-631
• Qiagen, Inc. (USA) IV-634
• QIAGEN GmbH (Germany) IV-634
• 236. Quality Biological, Inc. (USA) IV-636
• 237. R. Shadel, Inc. (USA) IV-636
• 238. Ramco Laboratories, Inc. (USA) IV-637
• 239. Reagecon Diagnostics Ltd. (Ireland) IV-637
• 240. ReaMetrix India Pvt., Ltd. (India) IV-638
• 241. Regis Technologies, Inc. (USA) IV-639
• 242. Repligen Corporation (USA) IV-640
• Table 212: Annual Sales Analysis: 2005-2006 (In US$ million) IV-640
• 243. Research Organics, Inc. (USA) IV-641
• 244. Retrogen, Inc. (USA) IV-641
• 245. Ricca Chemical Company (USA) IV-642
• 246. Roche Diagnostics (Schweiz) AG (Switzerland) IV-644
• Roche Diagnostics Corporation (USA) IV-647
• 247. Rockland Immunochemicals, Inc. (USA) IV-650
• 248. Santa Cruz Biotechnology, Inc. (USA) IV-650
• 249. Sanyo Chemical Industries Ltd. (Japan) IV-651
• 250. Scantibodies Laboratory, Inc. (USA) IV-660
• 251. Scharlau Chemie SA (Spain) IV-662
• 252. Scipac Ltd. (UK) IV-663
• 253. Scripps Laboratories, Inc. (USA) IV-664
• 254. Scytek Laboratories, Inc. (USA) IV-666
• 255. Sebia (France) IV-668
• Sebia Electrophoresis (USA) IV-668
• 256. Seracare Life Sciences, Inc. (USA) IV-669
• 257. Seradyn, Inc. (USA) IV-671
• 258. Serotec Ltd. (UK) IV-672
• 259. Serva Electrophoresis GmbH (Germany) IV-673
• 260. Severn Biotech Limited (UK) IV-674
• 261. SFRI Laboratoire (France) IV-675
• 262. Shimadzu Corporation (Japan) IV-676
• Table 213: Annual Sales Analysis: 2004-2005 (In ¥ million) IV-677
• Table 214: Annual Sales Analysis by Segment: 2004-2005 (In ¥ million) IV-678
• Table 215: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ million) IV-678
• 263. Sigma-Aldrich Corporation (USA) IV-681
• Table 216: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-682
• Table 217: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-682
• Table 218: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-682
• Table 219: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-682
• Table 220: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-682
• Table 221: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-683
• Safc Biosciences (USA) IV-689
• SAFC Supply Solutions (USA) IV-691
• 264. Skybio Limited (UK) IV-693
• 265. Solulink, Inc. (USA) IV-695
• 266. Southernbiotech (USA) IV-696
• 267. Spectral Diagnostics, Inc. (Canada) IV-697
• Table 222: First Quarter Sales Analysis: 2006-2007 (In Can$ million) IV-697
• Table 223: Annual Sales Analysis: 2005-2006 (In Can$ million) IV-697
• Table 224: Annual Sales Analysis by Quarter: 2005-2006 (In Can$ million) IV-698
• Table 225: Annual Sales Analysis by Geographic Region: 2005-2006 (In Can$ million) IV-698
• 268. Spectrum Laboratory Products, Inc. (USA) IV-700
• 269. Stabiligen (France) IV-701
• 270. Sterogene Bioseparations, Inc. (USA) IV-701
• 271. Stratagene, Inc. (USA) IV-702
• Table 226: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-703
• Table 227: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-704
• Table 228: Annual Sales Analysis: 2004-2005 (In US$ million) IV-704
• Table 229: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-704
• Table 230: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-704
• Table 231: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-704
• 272. Strategic Diagnostics, Inc. (USA) IV-707
• Table 232: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-707
• Table 233: Annual Sales Analysis: 2004-2005 (In US$ million) IV-708
• Table 234: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-708
• Table 235: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-708
• Strategic Biosolutions (USA) IV-713
• 273. Surmodics, Inc. (USA) IV-714
• Table 236: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-714
• Table 237: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-715
• Table 238: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-715
• Table 239: Annual Sales Analysis: 2004-2005 (In US$ million) IV-715
• Table 240: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-715
• Table 241: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-715
• 274. Takara Bio, Inc. (Japan) IV-718
• Table 242: Annual Sales Analysis: 2004-2005 (In ¥ billion) IV-718
• Clontech Laboratories, Inc. (USA) IV-720
• Takara Biotechnology (Japan) IV-722
• 275. Techne Corporation (USA) IV-723
• Table 243: First Quarter Sales Analysis: 2006-2007 (In US$ million) IV-724
• Table 244: First Quarter Sales Analysis by Business Segment: 2006-2007 (In US$ million) IV-724
• Table 245: Annual Sales Analysis: 2004-2006 (In US$ million) IV-724
• Table 246: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million) IV-725
• Table 247: Annual Sales Analysis by Business Segment: 2005-2006 (In US$ million) IV-725
• Table 248: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-725
• Table 249: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-725
• Table 250: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-725
• R&D Systems, Inc. (USA) IV-726
• 276. Tema Ricerca (Italy) IV-727
• 277. Tepnel Life Sciences PLC (UK) IV-728
• Table 251: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million) IV-728
• Table 252: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In £ million) IV-728
• Table 253: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In £ million) IV-728
• Table 254: Annual Sales Analysis: 2004-2005 (In £ million) IV-729
• Table 255: Annual Sales Analysis by Business Segment: 2004-2005 (In £ million) IV-729
• Table 256: Annual Sales Analysis by Geographic Region: 2004-2005 (In £ million) IV-729
• 278. The Binding Site, Inc. (USA) IV-731
• The Binding Site Ltd. (UK) IV-731
• 279. The Midland Certified Reagent Company (USA) IV-734
• 280. Thermo Fisher Scientific, Inc. (USA) IV-735
• Table 257: Annual Sales Analysis: 2004-2005 (In US$ million) IV-736
• Hyclone Laboratories, Inc. (USA) IV-739
• 281. TNB Laboratories, Inc. (Canada) IV-741
• 282. Tosoh Corporation (Japan) IV-742
• Table 258: First Quarter Sales Analysis: 2005-2006 (In ¥ billion) IV-744
• Table 259: Annual Sales Analysis: 2004-2005 (In ¥ billion) IV-744
• Table 260: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion) IV-744
• Table 261: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion) IV-744
• Tosoh Bioscience, Inc. (USA) IV-747
• Tosoh Bioscience GmbH (Germany) IV-748
• 283. Transgenomic, Inc. (USA) IV-749
• Table 262: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-750
• Table 263: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In US$ million) IV-750
• Table 264: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-750
• Table 265: Annual Sales Analysis: 2004-2005 (In US$ million) IV-750
• Table 266: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-751
• Table 267: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-751
• Table 268: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-751
• 284. Trevigen, Inc. (USA) IV-753
• 285. Trinity Biotech PLC (Ireland) IV-754
• Table 269: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-755
• Table 270: First Quarter Sales Analysis by Product: 2005-2006 (In US$ million) IV-755
• Table 271: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-755
• Table 272: Annual Sales Analysis: 2004-2005 (In US$ million) IV-756
• Table 273: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-756
• Table 274: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-756
• 286. Tripath Imaging, Inc. (USA) IV-759
• Table 275: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-759
• Table 276: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-760
• Table 277: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-760
• Table 278: Annual Sales Analysis: 2004-2005 (In US$ million) IV-760
• Table 279: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-760
• Table 280: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-760
• Table 281: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-760
• 287. U.S. Genomics, Inc. (USA) IV-761
• 288. United Chemical Technologies, Inc. (USA) IV-763
• 289. Vector Laboratories, Inc. (USA) IV-764
• 290. Vector-Best (Russia) IV-765
• 291. Virostat, Inc. (USA) IV-766
• 292. VMRD, Inc. (USA) IV-767
• 293. VWR International, Inc. (USA) IV-768
• Table 282: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-769
• Table 283: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-769
• Table 284: Annual Sales Analysis: 2004-2005 (In US$ million) IV-769
• Table 285: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-770
• 294. Wako Pure Chemical Industries Ltd. (Japan) IV-773
• Wako Chemicals USA, Inc. (USA) IV-774
• 295. Waters Corporation (USA) IV-775
• Table 286: Annual Sales Analysis: 2004-2005 (In US$ million) IV-776
• Table 287: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-776
• Table 288: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-777
• 296. Zenyth Therapeutics Limited (Australia) IV-784
• Table 289: Annual Sales Analysis: 2004-2005 (In A$ million) IV-784
• 297. Zeptometrix Corporation (USA) IV-786
• 298. Zeus Scientific, Inc. (USA) IV-787